We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Kisunla Eli Lilly Australia Pty Ltd
Product name
Kisunla
Sponsor
Accepted date
Oct-2023
Active ingredients
donanemab
Proposed indication
Is indicated to slow disease progression in adult patients with Alzheimer’s disease.
Application type
A (new medicine)
Publication date
Oct-2023